CNC · Centene Corporation

Summary

Centene Corporation announced it will present at the Barclays 28th Annual Global Healthcare Conference on March 10, 2026, reaffirming its 2026 full year GAAP diluted EPS guidance of greater than $1.98 and adjusted diluted EPS guidance of greater than $3.00. The Company also delivered a notice of partial redemption for $1,000,000,000 of its 4.25% Notes due December 15, 2027, on March 25, 2026.

Key takeaways

• Presentation at Barclays 28th Annual Global Healthcare Conference on March 10, 2026, at 8:30 a.m. EDT with live webcast.
• Reaffirmation of 2026 full year GAAP diluted EPS guidance > $1.98.
• Reaffirmation of 2026 full year adjusted diluted EPS guidance > $3.00.
• Notice of partial redemption for $1,000,000,000 aggregate principal of 4.25% Notes due December 15, 2027.
• Redemption date March 25, 2026, at 100% of principal plus accrued interest.
• $1,186,664,000 of 2027 Notes to remain outstanding post-redemption.